Table 2.

Fold change expression values of miRNAs in gastric adenocarcinomas^*

Down-regulated			Up-regulated
miRNA	Agilent	Exiqon	miRNA	Agilent	Exiqon
hsa-miR-1	−6.5	−2.4	ebv-miR-BART16	2.0	2.9
hsa-miR-133b	−6.1	−3.0	ebv-miR-BART3	2.1	3.0
hsa-miR-143*	−5.5	−2.5	ebv-miR-BART7	3.2	4.4
hsa-miR-145	−4.3	−2.5	hsa-miR-142-3p	20.5	3.8
hsa-miR-145*	−2.9	−3.3	hsa-miR-142-5p	3.6	3.9
hsa-miR-148a	−23.6	−2.4	hsa-miR-146a	5.8	3.7
hsa-miR-203	−41.2	−19.6	hsa-miR-146b-5p	2.3	4.5
hsa-miR-205	−63.2	−93.3	hsa-miR-155	3.7	2.7
hsa-miR-31	−5.0	−4.7	hsa-miR-192	3.4	5.8
hsa-miR-365	−8.2	−2.3	hsa-miR-194	32.2	6.7
hsa-miR-375	−15.1	−4.8	hsa-miR-20a	2.5	2.1
hsa-miR-451	−18.3	−3.7	hsa-miR-21	2.6	3.0
			hsa-miR-214	5.7	2.1
			hsa-miR-215	4.1	5.8
			hsa-miR-223	5.1	3.3
			hsa-miR-342-3p	4.2	2.3
			hsa-miR-765	5.8	3.1

^*Fold change (FC) expression levels of miRNAs in Agilent and Exiqon platforms. miRNAs were selected if their FC values were ≤ −2 (down-regulated) or ≥ 2 (up-regulated) in both platforms.